Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 15, Issue 6, 2000, Pages 867-871

  Filler, Guido ^a,c   Neuschulz, Ines ^a   Vollmer, Ilka ^a   Amendt, Peter ^a   Hocher, Berthold ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Calcineurin inhibitors; Cyclosporin microemulsion; Glucose tolerance; Insulin production; Renal transplantation; Tacrolimus

Indexed keywords

C PEPTIDE; CREATININE; CYCLOSPORIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TACROLIMUS;

ADOLESCENT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; INSULIN RELEASE; INSULIN SYNTHESIS; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY TRANSPLANTATION; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0034022832     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.6.867     Document Type: Article

References (22)

1. Scantlebury V, Shapiro R, Fung J et al. New onset of diabetes in FK506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 1991; 23: 3160-3170
2. Furth S, Neu A, Colombani P, Plotnick L, Turner ME, Fivush B. Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients. Pediatr Nephrol 1996; 10: 64-66
3. Shapiro R, Jordan ML, Scantlebury VP et al. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995; 59: 485-490
4. Shapiro R, Scantlebury VP, Jordan ML et al. Tacrolimus in pediatric renal transplantation. Transplantation. 1996; 62: 1752-1758
5. Filler G, Amendt P, vonBredow MA, Ehrich JHH. Transient diabetes mellitus and peripheral insulin resistance following tacrolimus intoxication in a child after renal transplantation. Nephrol Dial Transplant 1997; 12: 334-336
6. Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997; 16: 242-257
7. Fivush B, Green OC, Porter CC, Balfe JW, O'Regan S, Gahl WA (1987) Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child 141: 1087-1089
8. Filler G, Amendt P, von Bredow MA, Rohde W, Ehrich JHH. Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis. Eur J Pediatr 1998; 157: 738-742
9. Schmitz O, Orskov L, Lund S, Moller N, Christiansen JS, Orskov H. Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children. J Pediatr Endocrinol 1993; 6: 53-59
10. Filler G, Amendt P, Kohnert KD, Devaux S, Ehrich JHH. Glucose tolerance and insulin secretion in children before and during recombinant growth hormone Horm Res 1998; 50: 32-37
11. Filler G, Franke D, Amendt P, Ehrich JHH. Reversible diabetes mellitus during growth hormone therapy in chronic renal failure. Pediatr Nephrol 1998; 12: 405-407
12. Amendt P. Courses of blood sugar, insulin, growth hormone, free fatty acids and glycerin following intravenous and oral glucose load in children of diabetic mothers and of healthy control group. Acta Pediatr Acad Sci Hung 1975; 16: 281-298
13. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS. Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes 1984; 33: 717-720
14. Marble A, Ferguson BD. Diagnosis and classification of diabetes mellitus and the nondiabetic melliturias. In: Marble A, Krall LP, Bradley RF, Christlich AR, Soeldner JS (eds) Joslin's Diabetes Mellitus. 12th edn. Lea & Febinger, Philadelphia, 1985; 332-352
15. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263
16. Toffolo G, De Grandi F, Cobelli C. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modelling the secretion. Diabetes 1995: 44: 845-854
17. Krentz AJ, Dousset B, Mayer D et al. Metabolic effects of cyclosporin A and FK506 in liver transplant recipients. Diabetes 1993; 42: 1753-1759
18. Van Dop C, Donahoue P, Jabs KL, Bock GH, Fivush BA, Harmon WE. Glucose in tolerance in children with renal allografts and effect of growth hormone treatment. J Pediatr 1991; 118: 708-714
19. Kan H, Fujimoto S, Matsuda I. Erythrocyte insulin receptor and glucose tolerance test in children treated with prednisolone. Endocrinol Jpn. 1985; 32: 347-353
20. Mehls O, Haffner D, Wühl E, Tönshoff B, Schaefer F, Heinrich U. Growth hormone as a new treatment modality for short children with chronic renal failure. Horm Res 1996; 46: 230-235
21. Redmon JB, Olson LK, Armstrong MD, Greene MJ, Robertson RP. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invent 1996; 98: 2786-2793
22. Tamura K, Fujimura T, Tsutsumi T et al. Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. Transplant Proc 1995; 27: 357-361